Nuvve Holding Corp. (NVVE): Nasdaq/NYSE listing notice — Nuvve receives Nasdaq deficiency notice for bid price below $1.00

Nuvve Holding Corp.

Nasdaq notified Nuvve on March 27, 2024 that bid price closed below $1.00 for 30 consecutive business days.
Company has 180 days until September 23, 2024 to regain compliance by closing at $1.00+ for 10 consecutive days.
If compliance not met, Nuvve may be eligible for an additional 180-day cure period if it meets other listing standards.
Failure to regain compliance could lead to delisting from Nasdaq Capital Market; company may appeal to a hearings panel.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Nuvve Holding Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

March 27, 2024, Nuvve Holding Corp. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Nasdaq Marketplace Rule 5550(a)(2) (the “Bid Price Rule”). The notice has no immediate effect on the listing or trading of the Company's common stock and the common stock will continue to trade on The Nasdaq Capital Market under the sym

View on SEC.gov

Browse all listing & compliance notices →

Nuvve Holding Corp. filing history →

Source: SEC EDGAR

accession 0001836875-24-000038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.